Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Ankara, 06200, Turkey (Türkiye)
NCT Number: NCT07495527
Hip fractures are a major cause of morbidity and mortality, particularly in elderly patients. Accurate prediction of postoperative mortality is critical for risk stratification and clinical decision-making. Traditional scoring systems, such as the Nottingham Hip Fracture Score, have limitations in capturing complex, non-linear relationships among clinical variables.
This retrospective cohort study aims to develop and validate an artificial intelligence-based model to predict 30-day mortality in patients undergoing hip fracture surgery. Clinical and laboratory data of approximately 1000 patients operated between January 1, 2022 and December 1, 2025 will be extracted from electronic health records. Variables include demographic characteristics, comorbidities, laboratory parameters, perioperative data, and postoperative complications.
The performance of the artificial intelligence model will be evaluated and compared with conventional risk scoring systems. The study seeks to determine whether AI-based approaches can provide improved predictive accuracy for postoperative mortality in hip fracture patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Ankara, 06200, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients who underwent surgical treatment for hip fracture between January 1, 2022 and December 1, 2025 Age ≥18 years Availability of complete demographic, clinical, and laboratory data in the electronic health record system Documented 30-day follow-up or mortality status
Exclusion criteria
Patients with malignancy Patients undergoing revision hip surgery Patients with missing or incomplete key clinical or laboratory data required for analysis Patients with unavailable or undocumented 30-day mortality status
Time frame: 30 days after surgery and 1 year later
All-cause mortality occurring within 30 days following hip fracture surgery, determined from hospital records and electronic health data.
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Other
Development of an AI Model Based on Clinical Data to Predict 30-Day and 1-Year Mortality Rates After Hip Fracture Surgery: A Retrospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02425345
Arterial Occlusive Diseases, Arteriosclerosis
View Trial DetailsNCT06765083
Disease, Disease Attributes
Leeuwarden, Netherlands
View Trial DetailsNCT05971173
Femoral Fractures, Fractures, Bone
San Antonio, Texas, United States
View Trial DetailsNCT05765669
Bone Diseases, Bone Diseases, Metabolic
Coon Rapids, Minnesota, United States
View Trial Details